References
Timmers HJ, Taieb D, Pacak K. Current and future anatomical and functional imaging approaches to pheochromocytoma and paraganglioma. Horm Metab Res. 2012;44:367–72.
Han EJ, Lee SH, Song IU, et al. Simultaneous adrenal pheochromocytoma and carotid body paraganglioma in a woman. Nucl Med Mol Imaging. 2013;47:67–8.
Timmers HJ, Chen CC, Carrasquillo JA, et al. Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography. J Natl Cancer Inst. 2012;104:700–8.
Cantalamessa A, Caobelli F, Paghera B, et al. Role of 18F-FDG PET/CT, 123I-MIBG SPECT, and CT in restaging patients affected by malignant pheochromocytoma. Nucl Med Mol Imaging. 2011;45:125–31.
Treglia G, Castaldi P, Rindi G, et al. Diagnostic performance of Gallium-68 somatostatin receptor PET and PET/CT in patients with thoracic and gastroenteropancreatic neuroendocrine tumours: a meta-analysis. Endocrine. 2012;42:80–7.
Sharma P, Thakar A, Suman KCS, et al. 68Ga-DOTANOC PET/CT for baseline evaluation of patients with head and neck paraganglioma. J Nucl Med. 2013. doi:10.2967/jnumed.112.115485.
Rufini V, Treglia G, Montravers F, et al. Diagnostic accuracy of [18F]DOPA PET and PET/CT in patients with neuroendocrine tumors: a meta-analysis. Clin Transl Imaging. 2013;1:111-22.
Conflicts of interest
None.
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Castaldi, P., Treglia, G. & Rufini, V. Multifocal Head and Neck Paraganglioma Evaluated with Different PET Tracers: Comparison Between Fluorine-18-Fluorodeoxyglucose and Gallium-68-Somatostatin Receptor PET/CT. Nucl Med Mol Imaging 47, 218–219 (2013). https://doi.org/10.1007/s13139-013-0204-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13139-013-0204-x